botulinum toxin type A Injectable Product
RxNorm concept 1743429, clinical dose form group (scdg).
- RxCUI
- 1743429
- Term type
- Clinical dose form group (SCDG)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/1743429 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Related concepts
- botulinum toxin type A (IN, has ingredient)
- Dysport Injectable Product (SBDG, has tradename)
- Botox Cosmetic Injectable Product (SBDG, has tradename)
- Botox Injectable Product (SBDG, has tradename)
- Xeomin Injectable Product (SBDG, has tradename)
- Jeuveau Injectable Product (SBDG, has tradename)
- Daxxify Injectable Product (SBDG, has tradename)
- Letybo Injectable Product (SBDG, has tradename)
Linked data
NDCs
RxNorm links no NDCs to this concept.
Use it
Look up 1743429 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/1743429 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 1743429. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.